Claudia Allemani

Summary

Affiliation: Istituto Nazionale Tumori
Country: Italy

Publications

  1. ncbi Prognostic value of morphology and hormone receptor status in breast cancer - a population-based study
    C Allemani
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, I 20133 Milano, Italy
    Br J Cancer 91:1263-8. 2004
  2. ncbi Do pre-diagnostic drinking habits influence breast cancer survival?
    Claudia Allemani
    Department of Preventive and Predictive Medicine, Analytical Epidemiology Unit, Italy
    Tumori 97:142-8. 2011
  3. ncbi Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups
    Claudia Allemani
    Epidemiology Unit, Department of Preventive and Predictive Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy
    Cancer 107:352-60. 2006
  4. ncbi Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution study
    Claudia Allemani
    Analytical Epidemiology Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Eur J Cancer 46:1528-36. 2010
  5. ncbi Breast carcinoma survival in Europe and the United States
    Milena Sant
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Cancer 100:715-22. 2004
  6. ncbi Time trends of breast cancer survival in Europe in relation to incidence and mortality
    Milena Sant
    Department of Preventive and Predictive Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Int J Cancer 119:2417-22. 2006
  7. ncbi Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort
    Sabina Sieri
    Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, I 20133 Milan, Italy
    Cancer Epidemiol Biomarkers Prev 18:169-76. 2009
  8. ncbi Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project
    Milena Sant
    Department of Preventive and Predictive Medicine, Unit of Analytical Epidemiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Blood 116:3724-34. 2010
  9. ncbi Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe
    Milena Sant
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, I 20133 Milan, Italy
    Int J Cancer 106:416-22. 2003
  10. ncbi Salad vegetables dietary pattern protects against HER-2-positive breast cancer: a prospective Italian study
    Milena Sant
    Department of Preventive and Predictive Medicine, Unit of Etiological Epidemiology and Prevention, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Int J Cancer 121:911-4. 2007

Detail Information

Publications16

  1. ncbi Prognostic value of morphology and hormone receptor status in breast cancer - a population-based study
    C Allemani
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, I 20133 Milano, Italy
    Br J Cancer 91:1263-8. 2004
    ..Morphology and hormone receptor status were confirmed as significant survival predictors in this population-based study, even after adjusting for age and stage at diagnosis...
  2. ncbi Do pre-diagnostic drinking habits influence breast cancer survival?
    Claudia Allemani
    Department of Preventive and Predictive Medicine, Analytical Epidemiology Unit, Italy
    Tumori 97:142-8. 2011
    ..The aim of this study was to investigate the survival of women with breast cancer in relation to pre-diagnostic alcohol intake and other factors known to influence prognosis...
  3. ncbi Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups
    Claudia Allemani
    Epidemiology Unit, Department of Preventive and Predictive Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy
    Cancer 107:352-60. 2006
    ..S. To investigate these differences, the authors compared population-based HD survival in relation to morphologic type among populations in Europe and the U.S...
  4. ncbi Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution study
    Claudia Allemani
    Analytical Epidemiology Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Eur J Cancer 46:1528-36. 2010
    ....
  5. ncbi Breast carcinoma survival in Europe and the United States
    Milena Sant
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Cancer 100:715-22. 2004
    ..Breast carcinoma survival rates were found to be higher in the U.S. than in Europe...
  6. ncbi Time trends of breast cancer survival in Europe in relation to incidence and mortality
    Milena Sant
    Department of Preventive and Predictive Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Int J Cancer 119:2417-22. 2006
    ..In Estonia, low and stable survival in the context of increasing incidence and mortality suggests inadequate care...
  7. ncbi Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort
    Sabina Sieri
    Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, I 20133 Milan, Italy
    Cancer Epidemiol Biomarkers Prev 18:169-76. 2009
    ..However, it remains unclear to what extent serum hormone-breast cancer associations differ with receptor status...
  8. ncbi Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project
    Milena Sant
    Department of Preventive and Predictive Medicine, Unit of Analytical Epidemiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Blood 116:3724-34. 2010
    ..Differences in diagnostic and registration criteria are an important cause of incidence variation; however, different distribution of HM risk factors also contributes. The quality of population-based HM data needs further improvement...
  9. ncbi Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe
    Milena Sant
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, I 20133 Milan, Italy
    Int J Cancer 106:416-22. 2003
    ..Screening for breast cancer did not seem to affect the survival patterns once stage had been taken into account...
  10. ncbi Salad vegetables dietary pattern protects against HER-2-positive breast cancer: a prospective Italian study
    Milena Sant
    Department of Preventive and Predictive Medicine, Unit of Etiological Epidemiology and Prevention, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Int J Cancer 121:911-4. 2007
    ....
  11. ncbi Should we use incidence, survival or mortality to assess breast cancer trends in European women?
    Milena Sant
    Department of Predictive and Preventive Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Nat Clin Pract Oncol 3:228-9. 2006
  12. ncbi Breast cancer survival in the US and Europe: a CONCORD high-resolution study
    Claudia Allemani
    Cancer Research UK Cancer Survival Group, Department of Non communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom
    Int J Cancer 132:1170-81. 2013
    ..Differences in breast cancer survival between Europe and the US in the late 1990s were mainly explained by lower survival in Eastern Europe, where low healthcare expenditure may have constrained the quality of treatment...
  13. ncbi EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary
    Milena Sant
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Eur J Cancer 45:931-91. 2009
    ..For all cancers, 5-year survival conditional to surviving 1-year was higher and varied less with region, than the overall relative survival...
  14. ncbi Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States
    Milena Sant
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, I 20133, Milan, Italy
    Eur J Cancer 44:579-87. 2008
    ..Interpretation of marked variation in survival with morphology is complicated by classification inconsistencies. The completeness and standardisation of cancer registry morphology data needs to be improved...
  15. ncbi Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002
    Claudia Allemani
    Analytical Epidemiology Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Int J Cancer 132:2404-12. 2013
    ..Data on stage are not collected routinely or consistently, yet these data are essential for meaningful comparison of population-based survival, which provides vital information for improving breast cancer control...
  16. ncbi Regional inequalities in cancer care persist in Italy and can influence survival
    Milena Sant
    Descriptive Studies and Health Planning Unit, Department of Preventive and Predictive Medicine, Fondazione IRCSS Istituto Nazionale dei Tumori, Via Venezian 1, Milano, Italy Electronic address
    Cancer Epidemiol 36:541-7. 2012
    ..Population-based cancer registry studies of care patterns can help elucidate reasons for the marked geographic variation in cancer survival across Italy. The article provides a snapshot of the care delivered to cancer patients in Italy...